Skip to main content

New drug approved for duchenne muscular dystrophy

The U.S. Food and Drug Administration approved a drug for all patients with child onset muscular dystrophy, serving as the first of its kind.

Lead image for this article

The U.S. Food and Drug Administration approved a drug for all patients with child onset muscular dystrophy, the second drug approved for the disease and the first for everyone with the disorder. (Chicago Tribune)

The Texas Tribune Member Drive Fall 2021 banner

Support public-service journalism that’s always free to read.

Yes, I'll donate today